Skip to main content
. 2022 May 31;24(2):224–235. doi: 10.5853/jos.2021.02152

Table 1.

Association of lipids, lipoproteins, apolipoproteins, and their ratios with ischemic stroke, by etiology

Risk factor Large vessel
Small vessel
Cardioembolism
Undetermined
OR (95% CI) PAR (95% CI) OR (95% CI) PAR (95% CI) OR (95% CI) PAR (95% CI) OR (95% CI) PAR (95% CI)
LDL T2 vs. T1 1.02 (0.83–1.25) 5.9 (0.9–31.7) 0.88 (0.76–1.02) - 1.14 (0.80–1.62) 9.2 (1.4–42.6) 1.07 (0.89–1.28) 10.6 (4.1–24.5)
LDL T3 vs. T1 1.18 (0.96–1.47) 0.89 (0.77–1.04) 1.25 (0.84–1.85) 1.32 (1.09–1.59)
HDL T2 vs. T1 0.80 (0.66–0.97) 35.7 (27.1–45.3) 0.71 (0.61–0.82) 31.0 (24.6–38.2) 0.74 (0.52–1.05) 13.1 (2.6–45.9) 0.89 (0.74–1.07) 23.1 (15.3–33.4)
HDL T3 vs. T1 0.50 (0.40–0.62) 0.51 (0.44–0.60) 0.70 (0.47–1.05) 0.65 (0.53–0.79)
LDL/HDL T2 vs. T1 1.27 (1.03–1.58) 28.7 (20.3–39.0) 1.29 (1.10–1.51) 23.7 (17.0–31.9) 1.28 (0.90–1.84) 18.1 (7.1–38.7) 1.14 (0.94–1.38) 20.4 (12.7–31.1)
LDL/HDL T3 vs. T1 2.00 (1.61–2.50) 1.61 (1.38–1.88) 1.55 (1.02–2.34) 1.68 (1.39–2.03)
ApoB T2 vs. T1 1.03 (0.84–1.26) 13.4 (4.3–34.8) 1.06 (0.92–1.22) 5.8 (1.4–20.5) 0.88 (0.61–1.27) - 1.04 (0.87–1.25) 7.7 (1.3–35.3)
ApoB T3 vs. T1 1.44 (1.18–1.77) 1.14 (0.98–1.32) 1.05 (0.70–1.57) 1.19 (0.99–1.44)
ApoA1 T2 vs. T1 0.52 (0.42–0.63) 49.5 (39.0–59.9) 0.57 (0.49–0.66) 40.9 (35.2–46.8) 0.74 (0.52–1.07) 43.2 (28.9–58.8) 0.59 (0.49–0.71) 36.8 (29.4–45.0)
ApoA1 T3 vs. T1 0.31 (0.24–0.39) 0.36 (0.31–0.43) 0.43 (0.25–0.74) 0.41 (0.33–0.51)
ApoB/A1 T2 vs. T1 1.72 (1.37–2.16) 47.6 (40.1–55.2) 1.32 (1.14–1.53) 27.6 (21.6–34.6) 1.34 (0.90–1.98) 32.0 (17.5–51.0) 1.26 (1.04–1.52) 28.6 (20.9–37.8)
ApoB/A1 T3 vs. T1 3.10 (2.47–3.89) 1.91 (1.63–2.23) 1.99 (1.32–2.99) 2.02 (1.65–2.46)

All models adjusted for age, sex, geographic region, and potential confounders (smoking, hypertension, diabetes mellitus, physical activity, diet, psychosocial factors, waist-to-hip ratio, alcohol intake, and cardiac causes of stroke). For LDL and small vessel ischemic stroke, apoB and cardioembolism, PAR was negative and not reported.

OR, odds ratio; CI, confidence interval; PAR, population attributable risk; LDL, low-density lipoprotein; HDL, high-density lipoprotein; Apo, apolipoprotein.